肠道病毒疫苗接种与抗病毒治疗在1型糖尿病中的理论依据
本文综述既往与近期文献,评估1型糖尿病胰岛β细胞存在慢性、复发性及可能持续性肠道病毒感染的观点,探讨不同病毒株与多次打击假说,并指出仅少数β细胞受染且病毒可能复制缺陷。作者提出病毒可在多个层面参与1型糖尿病发病,最终需通过疫苗与抗病毒药物研究验证其因果作用。
要点
- 1型糖尿病中仅少数β细胞受肠道病毒感染,病毒可能复制缺陷。
- 病毒可能参与自身免疫触发、慢性刺激及β细胞功能障碍。
- 疫苗与抗病毒药物研究是验证病毒因果作用的唯一途径。
核心结论
- 病毒可能在1型糖尿病中于多个层面发挥作用,包括触发和慢性刺激自身免疫、产生炎症及促进β细胞功能障碍与应激,形成恶性循环。
- 只有通过疫苗接种和/或抗病毒药物研究才能最终证实或否定病毒在1型糖尿病中的作用。
研究设计与样本
- 本文为综述,回顾既往与近期文献以评估1型糖尿病胰岛β细胞慢性、复发性及可能持续性肠道病毒感染的相关证据。
主要发现
- 1型糖尿病中仅少数β细胞在任一给定时间似乎被感染,且肠道病毒可能变为复制缺陷,这或可解释为何极少从胰腺分离出病毒。
- 肠道病毒感染β细胞在很大程度上取决于宿主先天性和适应性免疫应答,包括β细胞自身发动的先天应答。
- 病毒可能由不同病毒株随时间持续,且1型糖尿病自然史中可能发生多次病毒打击。
临床怎么用
- 关注正在进行的疫苗和/或抗病毒药物研究,作为验证病毒在1型糖尿病中因果作用的唯一手段。
局限性
- 病毒在1型糖尿病中的作用仍未证实,且因胰腺组织难以获取,极少从1型糖尿病患者胰腺中分离出病毒。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In type 1 diabetes, pancreatic beta cells are destroyed by chronic autoimmune responses. The disease develops in genetically susceptible individuals, but a role for environmental factors has been postulated. Viral infections have long been considered as candidates for environmental triggers but, given the lack of evidence for an acute, widespread, cytopathic effect in the pancreas in type 1 diabetes or for a closely related temporal association of diabetes onset with such infections, a role for viruses in type 1 diabetes remains unproven. Moreover, viruses have rarely been isolated from the pancreas of individuals with type 1 diabetes, mainly (but not solely) due to the inaccessibility of the organ. Here, we review past and recent literature to evaluate the proposals that chronic, recurrent and, possibly, persistent enteroviral infections occur in pancreatic beta cells in type 1 diabetes. We also explore whether these infections may be sustained by different virus strains over time and whether multiple viral hits can occur during the natural history of type 1 diabetes. We emphasise that only a minority of beta cells appear to be infected at any given time and that enteroviruses may become replication defective, which could explain why they have been isolated from the pancreas only rarely. We argue that enteroviral infection of beta cells largely depends on the host innate and adaptive immune responses, including innate responses mounted by beta cells. Thus, we propose that viruses could play a role in type 1 diabetes on multiple levels, including in the triggering and chronic stimulation of autoimmunity and in the generation of inflammation and the promotion of beta cell dysfunction and stress, each of which might then contribute to autoimmunity, as part of a vicious circle. We conclude that studies into the effects of vaccinations and/or antiviral drugs (some of which are currently on-going) is the only means by which the role of viruses in type 1 diabetes can be finally proven or disproven.
引用
- Dunne JL, Richardson SJ, Atkinson MA, et al. Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes. Diabetologia. 2019. PMID: 30675626. doi:10.1007/s00125-019-4811-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。